Recently, a cytokine pathway analysis in the CSF of ALS patients report a negative correlation between IL-4 and IL-6 and shorter disease evolution towards death (<12 moths) and a positive correlation on patients with longer more settle disease progression (>12 months) [6, 12]. Here, IL6 is linked to amyotrophic lateral sclerosis.